A detailed history of Envestnet Asset Management Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 17,495 shares of INVA stock, worth $330,655. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,495
Previous 15,013 16.53%
Holding current value
$330,655
Previous $246,000 36.99%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$16.33 - $20.04 $40,531 - $49,739
2,482 Added 16.53%
17,495 $337,000
Q2 2024

Aug 08, 2024

BUY
$14.4 - $16.4 $216,187 - $246,213
15,013 New
15,013 $246,000
Q2 2023

Aug 04, 2023

BUY
$11.39 - $13.72 $19,214 - $23,145
1,687 Added 3.49%
50,031 $636,000
Q1 2023

May 11, 2023

SELL
$10.73 - $13.6 $1.98 Million - $2.51 Million
-184,232 Reduced 79.21%
48,344 $543,000
Q4 2022

Feb 07, 2023

BUY
$11.8 - $13.78 $329,349 - $384,613
27,911 Added 13.64%
232,576 $3.08 Million
Q3 2022

Nov 10, 2022

SELL
$11.61 - $15.22 $105,801 - $138,699
-9,113 Reduced 4.26%
204,665 $2.38 Million
Q2 2022

Aug 03, 2022

BUY
$14.32 - $19.88 $284,065 - $394,359
19,837 Added 10.23%
213,778 $3.16 Million
Q1 2022

May 04, 2022

BUY
$15.39 - $20.25 $365,066 - $480,350
23,721 Added 13.94%
193,941 $3.75 Million
Q4 2021

Feb 04, 2022

BUY
$15.91 - $18.72 $652,437 - $767,669
41,008 Added 31.74%
170,220 $2.94 Million
Q3 2021

Oct 07, 2021

BUY
$13.06 - $17.24 $231,344 - $305,389
17,714 Added 15.89%
129,212 $2.16 Million
Q2 2021

Aug 04, 2021

BUY
$11.45 - $13.96 $536,066 - $653,579
46,818 Added 72.38%
111,498 $1.5 Million
Q1 2021

May 04, 2021

BUY
$11.06 - $12.87 $188,993 - $219,922
17,088 Added 35.91%
64,680 $773,000
Q4 2020

Feb 02, 2021

SELL
$9.33 - $12.48 $69,191 - $92,551
-7,416 Reduced 13.48%
47,592 $590,000
Q3 2020

Oct 09, 2020

BUY
$10.33 - $14.49 $173,740 - $243,707
16,819 Added 44.04%
55,008 $575,000
Q2 2020

Jul 08, 2020

BUY
$11.49 - $15.26 $199,788 - $265,340
17,388 Added 83.59%
38,189 $534,000
Q1 2020

Apr 23, 2020

BUY
$8.11 - $15.23 $168,696 - $316,799
20,801 New
20,801 $245,000
Q1 2018

May 09, 2018

SELL
$13.8 - $16.99 $16,104 - $19,827
-1,167 Closed
0 $0
Q4 2017

Feb 20, 2018

BUY
$11.73 - $14.75 $13,688 - $17,213
1,167
1,167 $17,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.32B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.